首页> The Lancet> Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial

Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial

导出原文传递

翻译打印收藏纠错

第一作者： Mebazaa A.

作者： Mebazaa A. ^[1] ; Davison B. ^[2] ; Chioncel O. ^[3] ; Cohen-Solal A. ^[4] ; Diaz R. ^[5] ; Filippatos G. ^[6] ; Metra M. ^[7] ; Ponikowski P. ^[8] ; Sliwa K. ^[9] ; Voors A.A. ^[10] ; Edwards C. ^[11] ; Novosadova M. ^[12] ; Takagi K. ^[13] ; Damasceno A. ; Saidu H. ; Gayat E. ; Pang P.S. ; Celutkiene J. ; Cotter G.

作者单位： Université Paris Cité INSERM UMR-S 942 (MASCOT) ^[1] Emergency Institute for Cardiovascular Diseases “Prof C C Iliescu” University of Medicine “Carol ^[2] Estudios Clínicos Latinoamérica Instituto Cardiovascular de Rosario ^[3] National and Kapodistrian University of Athens School of Medicine Attikon University Hospital ^[4] Cardiology ASST Spedali Civili Department of Medical and Surgical Specialties Radiological Sciences ^[5] Department of Heart Diseases Wroclaw Medical University ^[6] Division of Cardiology Department of Medicine Groote Schuur Hospital University of Cape Town ^[7] Department of Cardiology University of Groningen University Medical Centre Groningen ^[8] Momentum Research ^[9] Faculty of Medicine Eduardo Mondlane University ^[10] Murtala Muhammed Specialist Hospital Bayero University Kano ^[11] Department of Emergency Medicine Department of Medicine Indiana University School of Medicine ^[12] Clinic of Cardiac and Vascular Diseases Institute of Clinical Medicine Faculty of Medicine Vilnius ^[13]

发布时间 2023-02-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交